Clinical Laserthermia Systems Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Clinical Laserthermia Systems
Access all reports
Clinical Laserthermia Systems AB is a Swedish medical technology company focused on developing minimally invasive laser-based treatment systems for cancer and neurosurgery. The company’s flagship product is the TRANBERG Thermal Therapy System, which is designed for precision laser ablation of solid tumors. This system enables high-precision, image-guided treatments for conditions such as prostate cancer and brain lesions. CLS is also advancing imILT (immunostimulating interstitial laser thermotherapy), which combines laser ablation with immune system stimulation to treat various types of tumors, including those in the liver, lungs, and pancreas. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CLS
Country
🇸🇪 Sweden